Record-Breaking Price Movement and Market Outperformance
On the day of this landmark achievement, Acutaas Chemicals Ltd surged by 5.79%, significantly outpacing the Sensex’s modest 0.43% gain. The stock’s intraday high of Rs. 2213.25 represents a 5.19% increase from its previous close, while outperforming its sector by 4.3%. This upward momentum is supported by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical strength.
Over various periods, the stock has consistently outperformed the broader market. Its one-year return stands at an impressive 83.96%, dwarfing the Sensex’s 7.76% gain. Year-to-date, Acutaas Chemicals Ltd has delivered a 30.70% return, contrasting with the Sensex’s decline of 6.77%. Even over the last three months, the stock has appreciated by 30.34%, while the Sensex fell by 7.30%. This trend extends to the one-month and one-week horizons, with the stock rising 12.11% and 1.85% respectively, against negative returns for the Sensex.
Longer-term performance further highlights the company’s market-beating credentials. Over three years, the stock has surged by 376.51%, vastly outperforming the Sensex’s 32.85% gain. Although five- and ten-year data for Acutaas Chemicals Ltd is not available, the recent trajectory firmly establishes it as a high-growth stock within its sector.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Financial Strength and Growth Metrics Underpinning the Rally
Acutaas Chemicals Ltd’s ascent to its all-time high is supported by a series of robust financial indicators. The company maintains a low average Debt to Equity ratio of zero, reflecting a debt-free balance sheet that enhances financial stability and flexibility.
Net sales have exhibited healthy long-term growth, expanding at an annual rate of 26.84%. Operating profit has grown even more impressively at 38.56% annually, signalling efficient cost management and operational leverage. The latest quarterly net sales figure of Rs. 393.18 crores represents a 43.4% increase compared to the previous four-quarter average, underscoring accelerating revenue momentum.
Net profit growth has been particularly strong, rising by 47.82%, with the company declaring outstanding results in December 2025. This marks the sixth consecutive quarter of positive results, highlighting consistent profitability and operational excellence.
Return on Capital Employed (ROCE) for the half-year period reached a peak of 21.30%, indicating effective utilisation of capital resources. Inventory turnover ratio also stands at a high 5.74 times, reflecting efficient inventory management and strong demand for products.
Institutional investors hold a significant 38.38% stake in the company, suggesting confidence from well-resourced market participants who typically conduct thorough fundamental analysis.
MarketsMojo ranks Acutaas Chemicals Ltd among the top 1% of over 4,000 stocks analysed, with a Mojo Score of 82.0 and a current Mojo Grade of Strong Buy, upgraded from Buy on 6 Oct 2025. The company is ranked 5th among Small Cap stocks and 15th across the entire market, reinforcing its status as a high-quality investment within the Pharmaceuticals & Biotechnology sector.
Valuation and Profitability Considerations
Despite the strong performance, the stock carries a premium valuation. The Price to Book Value stands at 12.1, reflecting a very expensive valuation relative to peers. Return on Equity (ROE) is 15.8%, which, while respectable, is moderate compared to the valuation multiples.
Profit growth has outpaced stock returns over the past year, with profits rising by 136% compared to the 83.96% stock price increase. This dynamic results in a Price/Earnings to Growth (PEG) ratio of 0.4, indicating that earnings growth is currently strong relative to the valuation.
Thinking about Acutaas Chemicals Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Sector Context and Market Capitalisation
Operating within the Pharmaceuticals & Biotechnology sector, Acutaas Chemicals Ltd’s market capitalisation grade is rated 3, reflecting a mid-sized company with significant growth potential. The company’s ability to consistently outperform the sector and broader market indices highlights its competitive positioning and operational strength.
The stock’s recent performance has been characterised by strong momentum, supported by solid fundamentals and favourable market dynamics. Trading well above all major moving averages, the stock demonstrates resilience and investor confidence in its business model and growth trajectory.
Summary of Key Performance Indicators
To summarise, Acutaas Chemicals Ltd’s key metrics include:
- All-time high stock price of Rs. 2213.25 on 5 Mar 2026
- One-year stock return of 83.96%, outperforming Sensex by over 76 percentage points
- Annual net sales growth rate of 26.84% and operating profit growth of 38.56%
- Net profit growth of 47.82% with six consecutive quarters of positive results
- ROCE at 21.30% and inventory turnover ratio of 5.74 times
- Institutional holdings at 38.38%, indicating strong backing from professional investors
- Mojo Score of 82.0 and upgraded Mojo Grade to Strong Buy as of 6 Oct 2025
- Price to Book Value of 12.1 and PEG ratio of 0.4, reflecting premium valuation supported by rapid profit growth
These indicators collectively illustrate a company that has delivered exceptional growth and value creation, culminating in the recent all-time high stock price.
Conclusion: A Milestone Reflecting Sustained Excellence
Acutaas Chemicals Ltd’s achievement of a new all-time high price is a testament to its sustained financial strength, operational efficiency, and market leadership within the Pharmaceuticals & Biotechnology sector. The company’s consistent growth in sales, profits, and returns on capital, combined with strong institutional support and a top-tier Mojo Score, underpin this milestone.
While the stock trades at a premium valuation, this is supported by robust earnings growth and superior market performance relative to peers and benchmarks. The current market environment and company fundamentals have aligned to propel Acutaas Chemicals Ltd to this significant valuation landmark, marking a notable chapter in its corporate journey.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
